PPP6C anticorps (Catalytic Subunit) (FITC)

N° du produit ABIN7169294

Détail du produit anti-PPP6C anticorps (FITC)

Antigène: PPP6C (Protein Phosphatase 6, Catalytic Subunit (PPP6C))

Épitope: AA 40-211, Catalytic Subunit

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PPP6C est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Serine/threonine-protein phosphatase 6 catalytic subunit protein (40-211AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur PPP6C

Antigène: PPP6C (Protein Phosphatase 6, Catalytic Subunit (PPP6C))

Autre désignation: PPP6C (PPP6C Produits)

Synonymes: anticorps PP6, anticorps PP6C, anticorps 2310003C10Rik, anticorps zgc:56227, anticorps ppp6c, anticorps PPP6C, anticorps pp6, anticorps MGC114734, anticorps DDBDRAFT_0168786, anticorps DDBDRAFT_0185210, anticorps DDB_0168786, anticorps DDB_0185210, anticorps CG12217, anticorps DmPpV-6A, anticorps Dmel\\CG12217, anticorps PPPV6A, anticorps PPV, anticorps PPV 6A, anticorps Ppv, anticorps dPP6, anticorps protein phosphatase 6 catalytic subunit, anticorps protein phosphatase 6, catalytic subunit, anticorps protein phosphatase 6, catalytic subunit L homeolog, anticorps serine/threonine-protein phosphatase 6 catalytic subunit, anticorps Protein phosphatase V, anticorps PPP6C, anticorps Ppp6c, anticorps ppp6c, anticorps ppp6c.L, anticorps ppp6C, anticorps PpV

Sujet:

Background: Catalytic subunit of protein phosphatase 6 (PP6). PP6 is a component of a signaling pathway regulating cell cycle progression in response to IL2 receptor stimulation. N-terminal domain restricts G1 to S phase progression in cancer cells, in part through control of cyclin D1. Downregulates MAP3K7 kinase activation of the IL1 signaling pathway by dephosphorylation of MAP3K7.

Aliases: FLJ92648 antibody, MGC12249 antibody, PP 6 antibody, PP6 antibody, PP6C antibody, PPP 6 antibody, PPP 6C antibody, PPP6 antibody, PPP6_HUMAN antibody, Ppp6c antibody, Protein phosphatase 6 catalytic subunit antibody, Serine/threonine protein phosphatase 6 antibody, Serine/threonine protein phosphatase catalytic subunit antibody, Serine/threonine-protein phosphatase 6 catalytic subunit antibody

UniProt: O00743